Restenosis Prevention

Stents have dramatically reduced the incidence of stenosis following percutaneous angioplasty. However, they are also known to restenose within months. Prevention of restenosis therefore depends on several factors:

  • Accurate stent placement and expansion, which avoids the occurrence of empty spaces for scar buildup
  • Use of targeted treatments to reduce neointimal hyperplasia and restenosis, which include:
    • Drug-eluting stents
    • Perivascular delivery which delivers the drug into the space around the artery
    • Delivery catheters
    • Antibody or peptide-linked drugs
    • Gene-based therapies
    • Cell-based therapies
    • Nanoparticle-based drug delivery
  • Lifestyle modifications as advised by the cardiologist, including regular exercise, lowering of blood pressure, quitting smoking and cutting down to one drink of alcohol, and a low-fat diet.
  • Use of appropriate medication to prevent platelet clots from forming

There are several categories of drugs for restenosis:

  • Drugs which inhibit coagulation, such as anticoagulants, antithrombotic agents and antiplatelet agents like clopidogrel and heparin
  • Anti-inflammatory agents such as dexamethasone and tranilast
  • Drugs which inhibit proliferation and oppose growth factors, such as ACE inhibitors, trapidil, tyrphostin
  • Cytostatic drugs which inhibit cell growth, like paclitaxel and rapamycin
  • Lipid-lowering agents such as statins
  • Antioxidants such as probucol or resveratrol

Vascular brachytherapy

Vascular brachytherapy is another technique used to prevent or treat a restenotic lesion. Here short-range ionizing therapy is used to inhibit neointimal hyperplasia, so as to prevent shrinkage of the arterial lumen after angioplasty. The radiation produces:

  • Inhibition of smooth muscle cell proliferation
  • Increased number of cells that enter the apoptosis pathway
  • Less fibrosis
  • Less negative remodeling, or healing which results in a shrunken lumen

Characteristic changes in irradiated vessels include:

  • Persistent absence of endothelium over the irradiated part of the vessel
  • Fibrin deposition over the bare area
  • Inflammatory cell infiltration of the vessel wall

Vascular brachytherapy can be used alone or following angioplasty of a restenotic lesion. This is performed through a special catheter placed for 10 minutes inside the blocked segment, and containing a source of short-term radiation.

References

Further Reading

Last Updated: Aug 23, 2018

Dr. Liji Thomas

Written by

Dr. Liji Thomas

Dr. Liji Thomas is an OB-GYN, who graduated from the Government Medical College, University of Calicut, Kerala, in 2001. Liji practiced as a full-time consultant in obstetrics/gynecology in a private hospital for a few years following her graduation. She has counseled hundreds of patients facing issues from pregnancy-related problems and infertility, and has been in charge of over 2,000 deliveries, striving always to achieve a normal delivery rather than operative.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thomas, Liji. (2018, August 23). Restenosis Prevention. News-Medical. Retrieved on December 22, 2024 from https://www.news-medical.net/health/Restenosis-Prevention.aspx.

  • MLA

    Thomas, Liji. "Restenosis Prevention". News-Medical. 22 December 2024. <https://www.news-medical.net/health/Restenosis-Prevention.aspx>.

  • Chicago

    Thomas, Liji. "Restenosis Prevention". News-Medical. https://www.news-medical.net/health/Restenosis-Prevention.aspx. (accessed December 22, 2024).

  • Harvard

    Thomas, Liji. 2018. Restenosis Prevention. News-Medical, viewed 22 December 2024, https://www.news-medical.net/health/Restenosis-Prevention.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.